EdgarLookup

Markvicka Taunia

Insider transactions at 2 companies

This page shows all SEC Form 4 filings attributed to Markvicka Taunia. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.

PCRX CRMD
Company Title Type Shares Price Value Date
0001318641 Chief Operating Officer Award / Grant 100,000 Sep 28, 2021
CRMD Purchase 14,500 $0.51 $7,395 May 15, 2017
CRMD Purchase 18,600 $1.65 $30,690 Aug 25, 2016
CRMD Purchase 4,000 $4.81 $19,240 Jun 23, 2015
PCRX SVP, Chief Commercial Officer Option Exercise 8,349 $5.49 $45,836 Mar 17, 2015
PCRX SVP, Chief Commercial Officer Purchase 230 $86.62 $19,923 Nov 7, 2014
PCRX Vice President, Commercial Sale 14,123 $51.36 $725,357 Nov 6, 2013
PCRX Vice President, Commercial Option Exercise 10,000 $5.49 $54,900 Sep 25, 2013
PCRX Vice President, Commercial Option Exercise 14,700 $1.61 $23,667 Aug 14, 2013
PCRX Vice President, Commercial Sale 29,754 $32.00 $952,128 Jul 12, 2013